| Title |
Persistence to statin treatment: A cohort study in Lithuania / |
| Authors |
Kirilova, Karina ; Trečiokienė, Indrė ; Bratčikovienė, Nomeda ; Qvarnström, Miriam ; Wettermark, Bjorn Gunnar Erik Evert |
| DOI |
10.1111/bcpt.14015 |
| Full Text |
|
| Is Part of |
Basic & Clinical Pharmacology & Toxicology.. Hoboken : Wiley. 2024, vol. 135, iss. 1, p. 43-51.. ISSN 1742-7835. eISSN 1742-7843 |
| Keywords [eng] |
adherence ; drug utilization ; persistence ; pharmacoepidemiology ; statins |
| Abstract [eng] |
Cardiovascular diseases are the main causes of death, and statins can reduce the risk of major vascular events. Lithuania is among the European countries with the highest cardiovascular mortality despite a rapidly increasing use of statins. Previous reviews have shown the problem of poor patient adherence, but there are limited studies from Eastern European countries. The aim of this study was to evaluate treatment persistence in new users of statins in Lithuania and to investigate factors associated with persistence. Dispensed prescriptions from patients aged >18 years old initiated on statins in 2018–2019 were included, and data were obtained from a national health insurance fund. Persistence was assessed by the proportion of patients who still had statins dispensed 1 year after the first dispensing. Factors associated with persistence were assessed using logistic regression. A total of 104 726 patients (41.3% men) were initiated on statin treatment. Only 41% of them continued statin use 1 year after initiation. Factors associated with higher persistence rate were older age, higher dose of statin, use of other medicines and use of statins as secondary prevention. Low persistence to statin therapy needs to be recognized by healthcare workers, pharmacists and policy makers to address this problem. |
| Published |
Hoboken : Wiley |
| Type |
Journal article |
| Language |
English |
| Publication date |
2024 |
| CC license |
|
